Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sph-biocad (hk) Limited

Clinical trials sponsored by Sph-biocad (hk) Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody BCD-261 put to the test in healthy volunteers Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 2

New antibody BCD-261 put to the test in healthy volunteers

Knowledge-focused Ongoing

This early-stage trial is testing a new drug called BCD-261 in 48 healthy Chinese volunteers aged 18 to 45. The goal is to check if it is safe and how the body processes it. No treatment benefit is expected; this study is purely about safety and dosing.

Phase 1 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Knowledge-focused

Last updated Jun 28, 2026 00:00 UTC